lead to aggressive HNSCC is crucial to identify new �druggable� targets for anti-cancer drug development. Our laboratory showed that miR-107 expression is reduced and functions as a tumor ... gene in HNSCC suggesting…
vary significantly within the same tumor sample. This not only complicates developing an optimal treatment for a cancer, but also challenges cancer diagnostics as well. Currently, personalized medicine in cancer…
making the rearrangement of metabolism from pathological development into normal development”. There were described the positive results of cancer treatment by the new method of cancer disease treatment which
those that can modulate autophagy. This review highlights the latest developments in understanding the interplay between autophagy and cervical cancer and discusses how natural products have emerged as promising…
compare breast cancer metastases between obese and non-obese women and to evaluate the effect of first-line metastatic chemotherapy in each group A retrospective study was performed ... groups. For arms A and B, the…
breast cancer therapy. The Oncompass Medicine Hungary Ltd., as a member of the ADMONT â?? â??Advanced Distributed Pilot Line for More-than-Moore Technologiesâ?� project aimed to develop ... blood-based cellular breast…
breast cancer therapy. The Oncompass Medicine Hungary Ltd., as a member of the ADMONT – “Advanced distributed Pilot Line for More-than-Moore Technologies” project aimed to develop a novel diagnostic ... blood-based…
Breast cancer is the most fatal form of cancer in females. Even with early diagnosis, 20% of women still develop metastases. Immunotherapy is being explored to provide a better treatment
ageing kinase that is responsible for a wide variety of diseases/disorders such as cancers, neurofibromatosis (NF), Alzheimer’s disease (AD), diabetes (type 2), hypertension, a variety of infectious ... huge, and…
Introduction: The ongoing trend of using orally-administered instead of intravenously-administered anti-cancer drugs improves patientsâÂ?Â? quality-of-life and reduces costs. However, as this trend facilitates…
gene encoding transforming growth factor-b1 (TGFB1) in the development of metastatic brain tumors in non-small cell lung cancer patients. The polymorphisms in TGFB1 rs4803455, rs1800469, and rs1800470 were ... rs1800469…
side-effects reducing efficacy of the anti-cancer treatment. In this study, OXL-loaded Nanoparticles (NPs) have been developed. NPs can accumulate more than its control formulation in the tumor
cancer cells and selectively release their therapeutic cargo in response to the reductive effect of intracellular enzymes in a tunable fashion. This seminar will discuss the rationale behind the development
Image guidance in radiation therapy for cervical cancer has evolved significantly in recent years, with new developments and flexible techniques emerging to improve treatment outcomes and reduce side effects. This…
optimal medication ratios in the combination. The combination therapy of chemo-antiangiogenesis for cancer is therefore excellent, and Nano formulations show a great deal of promise in this regard. Different ... assess…
types of tumors which will be presented, melanoma and breast cancer. In each of these cases, we have successfully developed in vitro tumor models which present with many features observed ... presented. In these studies…
vitro and in vivo screening and their anticancer potential against HCT colon cancer were assessed. The prepared nanoparticles were evaluated for various characteristic parameters such as UV–Visible spectral analysis…
Despite considerable research on K-Ras inhibitors, none had been developed until now. We synthesized nuclease-resistant synthetic miR-143 (miR-143#12), which strongly silenced K-Ras, its effector ... anti-proliferative…